Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
CorMedix Inc (NASDAQ: CRMD) closed the day trading at $7.63 up 1.60% from the previous closing price of $7.51. In other words, the price has increased by $1.60 from its previous closing price. On the day, 8.32 million shares were traded. CRMD stock price reached its highest trading level at $8.17 during the session, while it also had its lowest trading level at $7.6.
Ratios:
For a better understanding of CRMD, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 10.62 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 7.95. For the most recent quarter (mrq), Quick Ratio is recorded 1.73 and its Current Ratio is at 1.94. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.
On June 30, 2025, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $20.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Dec 30 ’25 when DUNTON ALAN W sold 20,000 shares for $13.00 per share. The transaction valued at 260,000 led to the insider holds 40,250 shares of the business.
Alan Dunton bought 20,000 shares of CRMD for $259,400 on Dec 30 ’25. On Dec 18 ’25, another insider, Todisco Joseph, who serves as the Chief Executive Officer of the company, sold 30,000 shares for $12.00 each. As a result, the insider received 360,000 and left with 509,496 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CRMD now has a Market Capitalization of 601160448 and an Enterprise Value of 694364480. As of this moment, CorMedix’s Price-to-Earnings (P/E) ratio for their current fiscal year is 3.72, and their Forward P/E ratio for the next fiscal year is 3.73. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.76 while its Price-to-Book (P/B) ratio in mrq is 1.60. Its current Enterprise Value per Revenue stands at 3.24 whereas that against EBITDA is 6.417.
Stock Price History:
The Beta on a monthly basis for CRMD is 1.40, which has changed by -0.3138489 over the last 52 weeks, in comparison to a change of 0.19362879 over the same period for the S&P500. Over the past 52 weeks, CRMD has reached a high of $17.43, while it has fallen to a 52-week low of $5.60. The 50-Day Moving Average of the stock is -30.47%, while the 200-Day Moving Average is calculated to be -32.31%.
Shares Statistics:
Over the past 3-months, CRMD traded about 3.11M shares per day on average, while over the past 10 days, CRMD traded about 5301300 shares per day. A total of 78.35M shares are outstanding, with a floating share count of 69.26M. Insiders hold about 12.13% of the company’s shares, while institutions hold 56.74% stake in the company. Shares short for CRMD as of 1765756800 were 16875402 with a Short Ratio of 5.42, compared to 1763078400 on 17445325. Therefore, it implies a Short% of Shares Outstanding of 16875402 and a Short% of Float of 21.63.
